Starting production this September, iNitrile’s pioneering new approach normalizes PPE protocols at work, minimizing waste, cost, and on-premise infection for companies across the United States
HOUSTON–(BUSINESS WIRE)–#COVID19—iNitrile, a leading medtech provider which invented and developed automated disposable glove dispensers to combat infections in organizations, and a subsidiary of Texas Medical Technology, a leading medtech company, raises $33 million to further develop its automatic glove dispenser process. The funding was raised by Jad Shraim, who is currently serving as Co-Founder and CFO of Texas Medical Manufacturing LLC. Shraim is expanding his current role to include iNitrile and will now also serve as the Co-Founder and CFO of the newly formed entity. The funds raised by Shraim fuel the team’s vision to build the biggest glove factory in the United States. Shraim will be joining the team headed by Dimitri Menin, President of Texas Medical Technology, and Omri Shaffran, Founder & CEO of Texas Medical Technology.
Jad Shraim has also worked as a Managing Director and a global market leader at Broadridge Financial Solutions, one of the largest financial technology solution firms globally. He’s an active entrepreneur who, alongside Omri, recognized the growing need for creating medical equipment at the outbreak of the pandemic. Jad saw an opportunity to provide preventative, life saving medical supplies that helped people on the front lines stay safe.
“I’m thrilled to be on-board, Omri and myself have shared the same vision since the pandemic started paralysing business,” says Jad Shraim, Co-Founder and CFO of iNitrile.
Personal protective equipment (PPE) has played a key role in curtailing the spread of COVID-19, and our ability to leverage it institutionally on a broad scale will decide the fate of economies across the globe. Variants are still emerging and the pace of U.S. vaccination efforts are slowing, meaning the threat of COVID-19 will prove difficult to shake off quickly. Companies understandably prioritized taking action over quality assessment at the onset of the pandemic, but maintaining operations safely and retaining workplace confidence now requires a systematic rethink. The mindset needs to shift from businesses remissively requesting their employees bring PPE items to work, to standardizing a manageable, automated, and non-wasteful protocol which seamlessly normalizes PPE safety.
With its state-of-the-art disposable glove dispenser, Texas Medical Technology’s iNitrile improves the user experience of disposable gloves, while also minimizing waste and cost. Most importantly, it eliminates the risk of user contamination. The machine first verifies an authorized user through its check-in function, utilizing radio-frequency identification to scan a badge or tag. The machine then prompts the user to sanitize their hands via a built-in sanitization machine. A compartment then opens, allowing the user to insert his/her hand into an inflated glove. The machine is suitable for both latex and nitrile non-powdered gloves.
iNitrile devices are interconnected and upload information to a cloud-based network, allowing users to maintain a clear overview of operations, requirements, and usage statistics. The iNitrile solution utilizes the creation of a management dashboard for internal users and a secure reporting system for customers hardware installations. This involved the creation of two Power BI Embedded reports that access data provided by an Azure SQL Database that is fed by the on-site hardware. These reports were later integrated into an existing ASP.NET web application that runs on a virtual machine in Microsoft Azure.
An easily accessible and plentiful supply of disposable gloves improves facility sanitation, as well as prevents inadvertent infection from being transmitted within a workplace or venue. Additionally, the ongoing use of the device enables organizations to reduce overhead on protective equipment supply costs, reducing up to 40 percent in glove waste over the first year of operation. iNitrile’s built-in, cloud-based, management software enables businesses to streamline stock management by managing the usage process and supply levels. This enables decision-makers to break down and quickly establish estimations for glove consumption, maintaining supply and reducing waste by up to 27 percent. The company recently disclosed that it is currently in the process of building a iNitrile factory in order to keep manufacturing up with growing demand.
“With the support of Texas Medical’s pedigree in PPE and our glove production starting imminently, I’m confident iNitrile will blaze a trail in the constantly-growing PPE sector,” adds Shraim.
About iNitrile
iNitrile is a Texas-based solutions company which develops applications used in aerospace, automotive and IT applications. The company is a leading developer of state-of-the-art disposable glove dispensers, which ensures users are provided with a contactless solution for authorizing, dispensing, and placing powder-free protective nitrile gloves at a workplace. The system employs RFID technology to identify the user, confirm their authorization for access gloves and the size requirements; and then dispenses that glove for each hand. The company is a subsidiary of Texas Medical Technology. For more information, visit http://initrile.com/
About Texas Medical Technology
Texas Medical Technology, one of the fastest growing companies in the U.S., has taken the supply challenges and placed them on its shoulders by shifting attention to COVID-related PPE. Providing an array of advanced tech and non-tech equipment to empower administrators to monitor potential medical crises and protect employees. For more info, please visit https://texasmedicaltechnology.com/
Contacts
Media Contact
Ilit Gluska
ReBlonde for Texas Medical
ilit@reblonde.com
Well-Capitalized Combined Company with Strong Financial Profile and 2023 Revenue of $246M, 28% from Recurring…
Chowis Co. Ltd. Skin, Hair and Scalp Solutions Provider Signs Agreement with Kolmar Korea to…
PORTLAND, OR / ACCESSWIRE / July 3, 2024 / Rose Villa Senior Living continues to…
Highlights:Total revenue of $9.9 million for Q1 2025, reflecting YoY growth of 31% from the…
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…